Nonmyeloablative allogeneic transplantation with or without (90)yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results

In 2008, we reported favorable 5-year outcomes of nonmyeloablative allogeneic stem cell transplantation after fludarabine, cyclophosphamide, rituximab (FCR) conditioning for relapsed and chemosensitive follicular lymphoma. However, innovative strategies were still needed to treat patients with chemo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood
Autori principali: Khouri, Issa F., Saliba, Rima M., Erwin, William D., Samuels, Barry I., Korbling, Martin, Medeiros, L. Jeffrey, Valverde, Rosamar, Alousi, Amin M., Anderlini, Paolo, Bashir, Qaiser, Ciurea, Stefan, Gulbis, Alison M., de Lima, Marcos, Hosing, Chitra, Kebriaei, Partow, Popat, Uday R., Fowler, Nathan, Neelapu, Sattva S., Samaniego, Felipe, Champlin, Richard E., Macapinlac, Homer A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2012
Soggetti:
Clinical Trials and Observations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4347306/
https://ncbi.nlm.nih.gov/pubmed/22586182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-03-417808
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi